cover of episode Indexes Hit By Late-Session Selling; Novo Nordisk, Fifth Third, APO In Focus

Indexes Hit By Late-Session Selling; Novo Nordisk, Fifth Third, APO In Focus

2024/1/4
logo of podcast Stock Market Today With IBD

Stock Market Today With IBD

Shownotes Transcript

No transcript made for this episode yet, you may request it for free.